Omada Health, a digital health provider focused on chronic-disease prevention and care, reported preliminary, unaudited revenue results for the fourth quarter and full fiscal year ending December 31, 2025. The company said preliminary revenue for Q4 2025 is approximately US $67 million, up from US $62 million in Q4 2024, reflecting continued demand for its virtual programs addressing conditions such as diabetes, hypertension and musculoskeletal disorders. For the full year, preliminary unaudited revenue is expected to be approximately US $246 million, an increase from US $228 million in FY 2024, driven by expanded payer and employer engagements and increased utilization of its digital therapeutic offerings.